DETAILED ACTION
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 1, 4-6 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Chemical Abstract Compound: RN 391208-94-9.
Regarding Claims 1, 4-6, RN 391208-94-9 :
PNG
media_image1.png
616
700
media_image1.png
Greyscale
RN 391208-94-9 reads on applicants’ applicants’ Formula 1 wherein X2 = n; X1 = C; R1 and R2 = H (per claims 1, 6); R = H (per claim 5)
RN 391208-94-9 reads on applicants’ applicants’ Formula 4-2 wherein X12 = N; X11 = C; R1 and R2 = H (per claim 4).
Allowable Subject Matter I
Claims 2-3 and 7are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.
The prior art of record fails to show:
Formulas 1-1 and 1-2 (per claim 2)
Z1 and Z2 (per claim 3)
Compounds (per claim 7)
Allowable Subject Matter II
The following is an examiner’s statement of reasons for allowance as applicant claims the device of claim 8
A search of the prior art fails to teach the invention of claim 8.
The closest prior art is Chemical Abstract Compound: RN 391208-94-9 which reads on applicants’ Formulas 1 and 4-2 but is not used in an OLED as required by independent claim 8.
Claims 8-13 allowed.
Conclusion
Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.”
Any inquiry concerning this communication or earlier communications from the examiner should be directed to GREGORY D CLARK whose telephone number is (571)270-7087. The examiner can normally be reached on 8AM-4PM M-F.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Chriss can be reached on 571-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/GREGORY D CLARK/Primary Examiner, Art Unit 1786
Prosecution Insights